These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 22401133

  • 21. Treatment of early rheumatoid arthritis in a multinational inception cohort of Latin American patients: the GLADAR experience.
    Cardiel MH, Pons-Estel BA, Sacnun MP, Wojdyla D, Saurit V, Marcos JC, Pinto MR, Cordeiro de Azevedo AB, da Silveira IG, Radominski SC, Ximenes AC, Massardo L, Ballesteros F, Rojas-Villarraga A, Oñate RV, Hernandez MP, Esquivel-Valerio JA, García-De La Torre I, Khoury VJ, Millán A, Soriano ER, GLADAR.
    J Clin Rheumatol; 2012 Oct; 18(7):327-35. PubMed ID: 23047532
    [Abstract] [Full Text] [Related]

  • 22. Prescriptions filled during pregnancy for drugs with the potential of fetal harm.
    Kulaga S, Zargarzadeh AH, Bérard A.
    BJOG; 2009 Dec; 116(13):1788-95. PubMed ID: 19832828
    [Abstract] [Full Text] [Related]

  • 23. Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: A nested case-control study.
    Ofori B, Oraichi D, Blais L, Rey E, Bérard A.
    Birth Defects Res B Dev Reprod Toxicol; 2006 Aug; 77(4):268-79. PubMed ID: 16929547
    [Abstract] [Full Text] [Related]

  • 24. Major malformations following exposure to nonsteroidal antiinflammatory drugs during the first trimester of pregnancy.
    Daniel S, Matok I, Gorodischer R, Koren G, Uziel E, Wiznitzer A, Levy A.
    J Rheumatol; 2012 Nov; 39(11):2163-9. PubMed ID: 22984274
    [Abstract] [Full Text] [Related]

  • 25. Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry.
    Atzeni F, Sarzi-Puttini P, Botsios C, Carletto A, Cipriani P, Favalli EG, Frati E, Foschi V, Gasparini S, Giardina A, Gremese E, Iannone F, Sebastiani M, Ziglioli T, Biasi D, Ferri C, Galeazzi M, Gerli R, Giacomelli R, Gorla R, Govoni M, Lapadula G, Marchesoni A, Salaffi F, Punzi L, Triolo G, Ferraccioli G.
    Autoimmun Rev; 2012 Dec; 12(2):225-9. PubMed ID: 22796281
    [Abstract] [Full Text] [Related]

  • 26. Adverse events with disease modifying antirheumatic drugs (DMARD): a cohort study of leflunomide compared with other DMARD.
    Cannon GW, Holden WL, Juhaeri J, Dai W, Scarazzini L, Stang P.
    J Rheumatol; 2004 Oct; 31(10):1906-11. PubMed ID: 15468352
    [Abstract] [Full Text] [Related]

  • 27. Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry.
    Weaver AL, Lautzenheiser RL, Schiff MH, Gibofsky A, Perruquet JL, Luetkemeyer J, Paulus HE, Xia HA, Leff JA, RADIUS Investigators.
    Curr Med Res Opin; 2006 Jan; 22(1):185-98. PubMed ID: 16393444
    [Abstract] [Full Text] [Related]

  • 28. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S, Cannon GW, Schiff M, Weaver A, Fox R, Olsen N, Furst D, Sharp J, Moreland L, Caldwell J, Kaine J, Strand V.
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [Abstract] [Full Text] [Related]

  • 29. Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?
    Askling J, van Vollenhoven RF, Granath F, Raaschou P, Fored CM, Baecklund E, Dackhammar C, Feltelius N, Cöster L, Geborek P, Jacobsson LT, Lindblad S, Rantapää-Dahlqvist S, Saxne T, Klareskog L.
    Arthritis Rheum; 2009 Nov; 60(11):3180-9. PubMed ID: 19877027
    [Abstract] [Full Text] [Related]

  • 30. Congenital structural anomalies in offspring of women with epilepsy--a population-based cohort study in Finland.
    Artama M, Ritvanen A, Gissler M, Isojärvi J, Auvinen A.
    Int J Epidemiol; 2006 Apr; 35(2):280-7. PubMed ID: 16280367
    [Abstract] [Full Text] [Related]

  • 31. Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study.
    Nørgård B, Pedersen L, Christensen LA, Sørensen HT.
    Am J Gastroenterol; 2007 Jul; 102(7):1406-13. PubMed ID: 17437503
    [Abstract] [Full Text] [Related]

  • 32. Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study.
    Nørgaard M, Pedersen L, Gislum M, Erichsen R, Søgaard KK, Schønheyder HC, Sørensen HT.
    J Antimicrob Chemother; 2008 Jul; 62(1):172-6. PubMed ID: 18400803
    [Abstract] [Full Text] [Related]

  • 33. The comparative one-year performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study.
    Heiberg MS, Koldingsnes W, Mikkelsen K, Rødevand E, Kaufmann C, Mowinckel P, Kvien TK.
    Arthritis Rheum; 2008 Feb 15; 59(2):234-40. PubMed ID: 18240258
    [Abstract] [Full Text] [Related]

  • 34. Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients.
    Wolfe F, Michaud K.
    Arthritis Rheum; 2004 Jun 15; 50(6):1740-51. PubMed ID: 15188349
    [Abstract] [Full Text] [Related]

  • 35. Tocilizumab use in pregnancy: Analysis of a global safety database including data from clinical trials and post-marketing data.
    Hoeltzenbein M, Beck E, Rajwanshi R, Gøtestam Skorpen C, Berber E, Schaefer C, Østensen M.
    Semin Arthritis Rheum; 2016 Oct 15; 46(2):238-245. PubMed ID: 27346577
    [Abstract] [Full Text] [Related]

  • 36. Perinatal use and discontinuation of disease-modifying anti-rheumatic drugs and biologics in women with rheumatoid arthritis: a cohort study.
    Rebić N, Sayre EC, Zusman EZ, Amiri N, Baldwin C, De Vera MA.
    Rheumatology (Oxford); 2020 Jul 01; 59(7):1514-1521. PubMed ID: 31628479
    [Abstract] [Full Text] [Related]

  • 37. Fetal growth and adverse birth outcomes in women receiving prescriptions for acetaminophen during pregnancy. EuroMap Study Group.
    Thulstrup AM, Sørensen HT, Nielsen GL, Andersen L, Barrett D, Vilstrup H, Olsen J.
    Am J Perinatol; 1999 Jul 01; 16(7):321-6. PubMed ID: 10614698
    [Abstract] [Full Text] [Related]

  • 38. [Congenital malformations and fetal growth of children with intrauterine exposure to anticonvulsants].
    Fonager KM, Larsen H, Pedersen L, Sørensen HT.
    Ugeskr Laeger; 2001 Nov 05; 163(45):6279-83. PubMed ID: 11723688
    [Abstract] [Full Text] [Related]

  • 39. Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL, Symmons DP, Watson KD, Silman AJ, British Society for Rheumatology Biologics Register.
    Arthritis Rheum; 2006 Jun 05; 54(6):1786-94. PubMed ID: 16736520
    [Abstract] [Full Text] [Related]

  • 40. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry.
    Horneff G, De Bock F, Foeldvari I, Girschick HJ, Michels H, Moebius D, Schmeling H, German and Austrian Paediatric Rheumatology Collaborative Study Group.
    Ann Rheum Dis; 2009 Apr 05; 68(4):519-25. PubMed ID: 18413440
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.